Physician profile
Neethi Dasu
NPI 1013444538
$5,894.59
in general payments reported to CMS, 2019-2025
14 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $296 · 2021: $461 · 2022: $1,072 · 2023: $1,624 · 2024: $2,198 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806 · Travel and Lodging: $1,741 · Consulting Fee: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,806.12 |
| Travel and Lodging | $1,741.26 |
| Consulting Fee | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,084.61 | 2021-2024 | Resolution 360 Clip, Exalt Model D, Axios |
| Olympus Corporation of The Americas | $612.56 | 2022 | |
| Abbvie INC. | $443.73 | 2019-2023 | Skyrizi |
| Astrazeneca Pharmaceuticals LP | $400.00 | 2024 | Imfinzi |
| E.R. Squibb & Sons, L.L.C. | $244.15 | 2021 | |
| Medtronic, INC. | $190.01 | 2024-2025 | Nexpowder |
| Endogastric Solutions, INC | $151.95 | 2023 | Esophyx |
| Olympus America INC. | $148.54 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $138.93 | 2020 | |
| Genzyme Corporation | $116.80 | 2021 | |
| Celgene Corporation | $115.73 | 2020 | |
| Acrotech Biopharma INC. | $110.37 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.78 | 2023 | Lifevest |
| Incyte Corporation | $41.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neethi Dasu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.